298 related articles for article (PubMed ID: 33445799)
1. Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1.
Völkner C; Liedtke M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445799
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the
Liedtke M; Völkner C; Jürs AV; Peter F; Rabenstein M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924575
[TBL] [Abstract][Full Text] [Related]
3. Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.
Yu D; Swaroop M; Wang M; Baxa U; Yang R; Yan Y; Coksaygan T; DeTolla L; Marugan JJ; Austin CP; McKew JC; Gong DW; Zheng W
J Biomol Screen; 2014 Sep; 19(8):1164-73. PubMed ID: 24907126
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
Yoon HJ; Jeong H; Lee HH; Jang S
J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
[TBL] [Abstract][Full Text] [Related]
5. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.
Prabhu AV; Kang I; De Pace R; Wassif CA; Fujiwara H; Kell P; Jiang X; Ory DS; Bonifacino JS; Ward ME; Porter FD
BMC Biol; 2021 Oct; 19(1):218. PubMed ID: 34592985
[TBL] [Abstract][Full Text] [Related]
6. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease.
Völkner C; Liedtke M; Untucht R; Hermann A; Frech MJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830064
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
8. An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene.
Li R; Pradhan M; Xu M; Roeder A; Beers J; Zou J; Liu C; Porter FD; Zheng W
Stem Cell Res; 2020 Apr; 44():101737. PubMed ID: 32114296
[TBL] [Abstract][Full Text] [Related]
9. Generation of the Niemann-Pick type C2 patient-derived iPSC line AKOSi001-A.
Völkner C; Peter F; Liedtke M; Krohn S; Lindner I; Murua Escobar H; Cimmaruta C; Lukas J; Hermann A; Frech MJ
Stem Cell Res; 2019 Dec; 41():101606. PubMed ID: 31669975
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.
Seker Yilmaz B; Baruteau J; Rahim AA; Gissen P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709131
[TBL] [Abstract][Full Text] [Related]
11. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.
Trilck M; Peter F; Zheng C; Frank M; Dobrenis K; Mascher H; Rolfs A; Frech MJ
Brain Res; 2017 Feb; 1657():52-61. PubMed ID: 27923633
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
[TBL] [Abstract][Full Text] [Related]
13. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
[TBL] [Abstract][Full Text] [Related]
14. Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks.
Trilck M; Hübner R; Seibler P; Klein C; Rolfs A; Frech MJ
Orphanet J Rare Dis; 2013 Sep; 8():144. PubMed ID: 24044630
[TBL] [Abstract][Full Text] [Related]
15. Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.
Efthymiou AG; Steiner J; Pavan WJ; Wincovitch S; Larson DM; Porter FD; Rao MS; Malik N
Stem Cells Transl Med; 2015 Mar; 4(3):230-8. PubMed ID: 25637190
[TBL] [Abstract][Full Text] [Related]
16. Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate Metabolism.
Gläser A; Hammerl F; Gräler MH; Coldewey SM; Völkner C; Frech MJ; Yang F; Luo J; Tönnies E; von Bohlen Und Halbach O; Brandt N; Heimes D; Neßlauer AM; Korenke GC; Owczarek-Lipska M; Neidhardt J; Rolfs A; Wree A; Witt M; Bräuer AU
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599915
[TBL] [Abstract][Full Text] [Related]
17. Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.
Vance JE; Karten B
J Lipid Res; 2014 Aug; 55(8):1609-21. PubMed ID: 24664998
[TBL] [Abstract][Full Text] [Related]
18. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
Boadu E; Nelson RC; Francis GA
Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
[TBL] [Abstract][Full Text] [Related]
19. Altered vitamin E status in Niemann-Pick type C disease.
Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
[TBL] [Abstract][Full Text] [Related]
20. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for
Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
